Physician profile
Matthew Risdon Galliano
NPI 1437119526
$18,825.04
in general payments reported to CMS, 2019-2025
16 companies · $3,556 in 2025
The $3,556 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $8,008 · 2021: $171 · 2022: $34.24 · 2023: $2,796 · 2024: $4,086 · 2025: $3,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5,336 · Consulting Fee: $2,500 · Travel and Lodging: $1,344 · Food and Beverage: $1,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,336.44 |
| Consulting Fee | $2,500.00 |
| Travel and Lodging | $1,343.65 |
| Food and Beverage | $1,257.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $7,758.82 | 2020 | |
| Fusion Orthopedics USA, LLC | $7,219.09 | 2023-2025 | Minilock, Small Bone Plates |
| Medline Industries LP | $2,492.26 | 2020-2025 | Medline Industries, INC. |
| Fusion Orthopedics, LLC. | $644.92 | 2021-2024 | Polylock Minilock, Minilock |
| Titan Surgical Group, LLC | $162.62 | 2024 | |
| Wright Medical Technology, INC. | $152.54 | 2019 | |
| International Life Sciences | $140.93 | 2020 | |
| Acumed LLC | $57.61 | 2025 | Acumed, Innate Implant |
| Endo USA, INC. | $40.79 | 2025 | Xiaflex |
| Linvatec Corporation | $34.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.60 | 2021 | |
| Ani Pharmaceuticals, INC. | $22.54 | 2025 | Purified Cortrophin Gel |
| Crossroads Extremity Systems, LLC | $21.27 | 2019 | |
| Bioventus LLC | $17.13 | 2025 | Exogen Ultrasound Bone Healing System |
| Fidia Pharma USA INC. | $14.88 | 2025 | Triluron, Hymovis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $14.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Galliano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.